[1] |
Zhao H, Liu F, Yue Z, et al.Association of hepatic vein lipiodol tram-track sign during transcatheter arterial chemoembolization with perioperative death.J Int Med Res, 2017,45:1148-1157.
|
[2] |
刘开才, 吕维富, 周春泽,等.TACE治疗原发性肝细胞癌合并门静脉癌栓疗效及影响因素. 中国介入影像与治疗学, 2018, 15:331-336.
|
[3] |
Han D H, Joo D J, Kim M S, et al.Living donor liver transplantation for advanced hepatocellular carcinoma with portal vein tumor thrombosis after concurrent chemoradiation therapy.Yonsei Med J, 2016,57:1276-1281.
|
[4] |
中华医学会放射肿瘤学分会.2016年原发性肝癌放疗共识.中华放射肿瘤学杂志, 2016, 25:1141-1150.
|
[5] |
曾昭冲. 肝细胞癌的立体定向放射治疗. 中华肿瘤杂志, 2015,37:650-655.
|
[6] |
中国抗癌协会肝癌专业委员会中国抗癌协会临床肿瘤学协作专业委员会中华医学会肝病学会肝癌学组全国肝胆肿瘤及移植病理协作组.原发性肝癌规范化病理诊断方案专家共识.中华医学杂志,2011,91:802-804.
|
[7] |
Vincenzo Cuccurullo, Luigi Mansi.AJCC cancer staging handbook: from the AJCC cancer staging manual (7th edition).Eur J Nucl Med Mol I, 2011, 38:408.
|
[8] |
吴旭波, 常奇蒙, 王建法,等.趋化因子配体18在肝细胞癌中的表达及其对临床病理特征和预后的影响. 肝脏, 2018, v.23:23-25,30.
|
[9] |
Ronald J, Nixon A B, Marin D, et al.Pilot evaluation of angiogenesis signaling factor response after transcatheter arterial embolization for hepatocellular carcinoma. Radiology, 2017, 285:311-318.
|
[10] |
翟天宇,王健东.MRI评估肝细胞癌经导管动脉化疗栓塞术疗效的研究进展. 中华解剖与临床杂志,2017,22:244-247.
|
[11] |
孙文兵. 射频消融在肝细胞癌综合治疗中的作用.中华肝胆外科杂志,2015,21:591-595.
|
[12] |
赵中伟,纪建松,邵国良,等.肝动脉化疗栓塞联合射频消融治疗包膜下肝癌的疗效和安全性.中华放射学杂志,2016,50:380-383.
|
[13] |
王鹤,董家鸿,卢实春,等.手术切除与射频消融治疗原发性肝癌患者预后比较.实用肝脏病杂志,2017,20:337-340.
|
[14] |
Chan LC, Chiu SKW, Chan SL.Stereotactic radiotherapy for hepatocellular carcinoma: Report of a local single-centre experience.Hong Kong Med J, 2011, 17:112-118.
|
[15] |
王俊男,曹飞,叶小飞,等.立体定向放疗联合肝动脉化疗栓塞治疗原发性肝癌系统评价和Meta分析.中华肿瘤防治杂志,2018,25:60-67.
|